
LivaNova PLC LIVN
$ 63.28
-1.43%
Annual report 2025
added 02-25-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
54.5 M |
Market Cap[1] |
$ 3.45 B |
EBITDA (LTM) |
$ -34.2 M |
P/E (LTM) |
-14.56 |
P/S (LTM) |
2.6 |
EPS (LTM) |
-4.41 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 13.11 | 2.38 % | $ 1.77 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.65 | 3.45 % | $ 40.5 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.3 | 2.48 % | $ 124 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 11.25 | -4.5 % | $ 319 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 93.92 | -1.01 % | $ 12.7 B | NYSE,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.14 | -0.93 % | $ 1.3 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Electromed
ELMD
|
$ 26.56 | 0.3 % | $ 225 M | NYSE American | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.09 | -0.62 % | $ 377 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.17 | 1.57 % | $ 61.8 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.27 | 0.02 % | $ 51.7 M | Nasdaq Global Select Market | ||
|
Butterfly Network
BFLY
|
$ 5.47 | 2.53 % | $ 1.16 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Delcath Systems
DCTH
|
$ 10.95 | 0.97 % | $ 392 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.11 | 4.72 % | $ 18.8 M | Nasdaq Global Select Market | ||
|
Insulet Corporation
PODD
|
$ 189.05 | -0.27 % | $ 13.3 B | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 39.03 | 1.69 % | $ 1.21 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 55.02 | -2.22 % | $ 1.62 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 84.16 | -2.14 % | $ 2.92 B | NYSE,SPB | ||
|
PAVmed
PAVM
|
$ 8.8 | -2.22 % | $ 5.9 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 84.42 | 0.2 % | $ 49.4 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.47 | - | $ 6.85 M | Nasdaq Capital Market | ||
|
MiMedx Group
MDXG
|
$ 3.43 | -0.15 % | $ 507 M | Nasdaq Global Select Market | ||
|
Stryker Corporation
SYK
|
$ 327.34 | -0.05 % | $ 125 B | NYSE,SPB | ||
|
Tactile Systems Technology
TCMD
|
$ 25.12 | 0.2 % | $ 575 M | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.